These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1606523)

  • 1. Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma.
    Winkelstein A; Jordan PS
    Clin Rev Allergy; 1992; 10(1-2):39-58. PubMed ID: 1606523
    [No Abstract]   [Full Text] [Related]  

  • 2. [Secondary deficiencies of humoral immunity in hematology: what management?].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():1. PubMed ID: 17893958
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin therapy in patients with multiple myeloma.
    Chapel HM; Hargreaves R; Lee M; Pamphilon D
    Immunodeficiency; 1993; 4(1-4):77-8. PubMed ID: 8167740
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous immune globulin in chronic lymphocytic leukaemia.
    Gamm H; Huber C; Chapel H; Lee M; Ries F; Dicato MA
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):17-20. PubMed ID: 8033428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypogammaglobulinemia and immunodeficiency in multiple myeloma and chronic lymphoid leukemia].
    Matthes T; Jandus P
    Rev Med Suisse; 2023 Apr; 19(821):668-673. PubMed ID: 37017348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various doses of intravenous polyclonal IgG on in vivo levels of 12 pneumococcal antibodies in patients with chronic lymphocytic leukaemia and multiple myeloma.
    Sklenar I; Schiffman G; Jønsson V; Verhoef G; Birgens H; Boogaerts M; Ferrant A; Christensen BE; Hasle H; Drivsholm A
    Oncology; 1993; 50(6):466-77. PubMed ID: 8233289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of immunoglobulin synthesis using the hemolytic plaque technic in lymphoproliferative syndromes of B-cell lineage].
    González Echeverría FJ; Hernández Navarro F; Ancín Chandia MT; León Moya V; López Borrasca A
    Sangre (Barc); 1988 Aug; 33(4):269-76. PubMed ID: 3055364
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoglobulin therapy in a patient with chronic lymphocytic leukemia and recurrent infections.
    Bottino GG; Bottino JC; Greene R; Ballard HS
    N Y State J Med; 1988 Nov; 88(11):597-9. PubMed ID: 3148874
    [No Abstract]   [Full Text] [Related]  

  • 9. Secondary antibody deficiencies.
    Dhalla F; Misbah SA
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):505-13. PubMed ID: 26406183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the treatment of chronic lymphocytic leukemia: defining the role of intravenous immunoglobulin.
    Besa EC
    Semin Hematol; 1992 Jul; 29(3 Suppl 2):14-23. PubMed ID: 1380736
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes.
    Bonilla FA
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):803-19, ix. PubMed ID: 18940575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunodeficiency of chronic lymphocytic leukaemia.
    Hamblin AD; Hamblin TJ
    Br Med Bull; 2008; 87():49-62. PubMed ID: 18755702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G treatment of secondary immunodeficiencies in the era of novel therapies.
    Seppänen M
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):10-3. PubMed ID: 25546744
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intravenous immunoglobulin preparations for treatment of lymphoreticular malignancies in adults].
    Frydecka I
    Postepy Hig Med Dosw; 2002; 56 Suppl():53-8. PubMed ID: 12661415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?
    Barmettler S; Price C
    J Allergy Clin Immunol; 2015 Nov; 136(5):1407-9. PubMed ID: 26277594
    [No Abstract]   [Full Text] [Related]  

  • 16. [T and B lymphocytes in humans. Lymphocytes with membrane immunoglobulins in normal and pathological conditions].
    Aiuti F; Lacava V; D'Asero C; Ciarla MV; D'Amelio R; Fiorilli M
    Recenti Prog Med; 1973 Feb; 54(2):124-51. PubMed ID: 4541383
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypogammaglobulinaemia.
    Yong PF; Chee R; Grimbacher B
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):691-713, vii. PubMed ID: 18940570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.
    Allegra A; Tonacci A; Musolino C; Pioggia G; Gangemi S
    Front Immunol; 2021; 12():738915. PubMed ID: 34759921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic lymphoid leukemia and intravenous immunoglobulins].
    Feugier P; Tomowiak C; Daguindau N; Perrot A
    Rev Med Interne; 2007 Jun; 28 Spec No 2():2-4. PubMed ID: 17893959
    [No Abstract]   [Full Text] [Related]  

  • 20. Case 22-2005: intravenous immune globulin in chronic lymphocytic leukemia.
    Newcom SR
    N Engl J Med; 2005 Oct; 353(17):1862-3; author reply 1862-3. PubMed ID: 16251548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.